These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23346666)
1. Pathophysiology of adverse cutaneous drug reactions--applied perceptions: Part II. Sehgal VN; Verma P; Bhattacharya SN Skinmed; 2012; 10(6):373-83. PubMed ID: 23346666 [TBL] [Abstract][Full Text] [Related]
2. Physiopathology of adverse cutaneous drug reactions--applied perceptions: part I. Sehgal VN; Verma P; Bhattacharya SN Skinmed; 2012; 10(4):232-7. PubMed ID: 23008941 [TBL] [Abstract][Full Text] [Related]
3. Severe cutaneous adverse reactions. Grover S Indian J Dermatol Venereol Leprol; 2011; 77(1):3-6. PubMed ID: 21220872 [No Abstract] [Full Text] [Related]
4. Getting under the skin of adverse drug reactions. Hempel C; Martin C Orthopedics; 2012 Oct; 35(10):872-6. PubMed ID: 23027476 [TBL] [Abstract][Full Text] [Related]
5. Fixed drug eruption: state of the art. Ozkaya E J Dtsch Dermatol Ges; 2008 Mar; 6(3):181-8. PubMed ID: 18076661 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases. Seneschal J; Milpied B; Taieb A Chem Immunol Allergy; 2012; 97():203-16. PubMed ID: 22613864 [TBL] [Abstract][Full Text] [Related]
7. The adverse reactions of vehicles and externally applied drugs. Zesch A Acta Derm Venereol Suppl (Stockh); 1987; 134():22-9. PubMed ID: 2965483 [No Abstract] [Full Text] [Related]
8. Cutaneous drug reactions. Rubianes EI; Martín RF; Picó M; González JR Bol Asoc Med P R; 1990 Oct; 82(10):434-42. PubMed ID: 2150483 [TBL] [Abstract][Full Text] [Related]
9. Skin: major target organ of allergic reactions to small molecular weight compounds. Merk HF; Baron JM; Neis MM; Obrigkeit DH; Karlberg AT Toxicol Appl Pharmacol; 2007 Nov; 224(3):313-7. PubMed ID: 17462686 [TBL] [Abstract][Full Text] [Related]
10. [Drug eruptions caused by beta-blockers]. Bonnetblanc JM Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136 [TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions: reporting and evaluating cutaneous reactions. Stern RS; Wintroub BU Adv Dermatol; 1987; 2():3-17. PubMed ID: 2978937 [No Abstract] [Full Text] [Related]
12. Dermatologic drug reactions. McKenna JK; Leiferman KM Immunol Allergy Clin North Am; 2004 Aug; 24(3):399-423, vi. PubMed ID: 15242718 [TBL] [Abstract][Full Text] [Related]